- Evolving Regulatory Environment: Significant regulatory reforms across Latin American countries aiming to align with international standards (e.g., ICH guidelines)
- Opportunities Arising from Regulatory Changes: Faster approval timelines enabling quicker trial initiation
- Role of Vendors in Fostering Opportunities: Need for vendors to adapt to local regulatory nuances and evolving compliance requirements
- Turning to Latin America for a genetically diverse population, valuable for global clinical research, but also understanding the need for culturally sensitive patient engagement strategies to improve recruitment and retention
Archives: Agenda
CLOSING PANEL DISCUSSION: Why do drugs fail clinical trials?
- Changing how researchers select potential patients for better success rates
- How to improve drug efficacy and patient safety before it’s too late
- Back to square one: Differentiating with simpler, patient-centric protocols and optimised study design
- Avoiding disappointing results by implementing the right technology tools to advance your trial
- Lessons learned to mitigate trial failures
Moderator: Sumeet Ambarkhane, Chief Medical Officer, Pathios Therapeutics
Placing fear reduction at the core of the patient experience strategy: Assessing the impact of diminished anxiety and increased sense of control for oncology clinical trials
- Improving the sense of security to reduce unnecessary suffering and distress for patients
- Understanding the different types of patients and their individual response behaviours
- Being hyper aware of cultural differences and biases to ensure sensitivity and effective outcomes for all
- Sharing best practice on effective strategies with case studies and examples to help reduce patient drop out rate
CAR-T Crossroads: Oncology insights driving rare disease innovation
- An overview of CAR-T trial trends in Oncology
- How we can apply regulatory, design, logistical and operational lessons learned to the new wave of CAR-T trials in the rare disease space
Morning refreshments and networking
KEYNOTE: Financing Biotechs: The real cost of innovation
- Challenges in securing initial funding/additional financing
- Expense associated with drug development
- Loss of new pharmaceutical technologies and cutting-edge compounds
- Impact on patients in need of options
From barriers to progress: Advancing oncology trial success through a patient-first approach in eClinical technology
- Focus on the challenges patients face in trials: Learn what the data reveals about barriers to oncology trial participation and the toll of patient dropout.
- Learn how technology (when done right) can make trials easier for oncology patients: Explore solutions like travel support, streamlined patient payments, and eCOA.
- Hear success stories: Find out how recent case studies of eClinical solutions improved the patient and site experience.
- See how a Platform approach creates a smoother experience for patients and sites: Get the latest on the Suvoda-Greenphire merger and its suite of eight unified solutions.